Is self-administered DMPA an answer to contraception access in the post-Roe era?

J Fam Pract. 2023 Mar;72(2):84-86. doi: 10.12788/jfp.0558.ABSTRACTCompared with provider-administered depot medroxyprogesterone acetate, a prefilled formulation may offer patients improved access to effective contraception.PMID:36947783 | PMC:PMC10032666 | DOI:10.12788/jfp.0558

Source: The Journal of Family Practice - March 22, 2023 Category: Practice Management Authors: Lindsay Nakaishi Gregory Castelli Source Type: research